The global Cell And Gene Therapy Manufacturing Market is anticipated to create phenomenal growth opportunities over the forecast period by registering a CAGR of 29% from 2023 to 2033. The global market reached a valuation of around US$ 19.3 Billion in 2023 and is expected to surpass a valuation of around US$ 240 Billion by …
Category Archives: Healthcare Trends
Aquaculture Vaccine Market Poised to reach US$ 913.6 Million by 2033, Fuelled by Rising Global Aquaculture Production: FMI Study
The global Aquaculture Vaccines Market is worth US$ 406 Million as of now and is expected to reach US$ 913.6 Million by the year 2033 at a CAGR of 8.5% between 2023 and 2033. Surge in aquaculture is the factor majorly driving the aquaculture vaccines market. There is an ever-increasing demand for canned fish products, …
Encephalitis Management Market Envisioned to Exceed US$ 34.08 Billion by 2033, Driven by Advances in Encephalitis Recovery | FMI
The global Encephalitis Treatment Market is projected to expand at a moderate CAGR of 5.4% from 2023 to 2033. The market is set to reach a valuation of US$ 34.08 billion by 2033, rising from US$ 20.14 billion in 2023. The rapid technological progress of the healthcare sector, rising cases of encephalitis, and a surge …
Synergistic Approaches and Innovative Assays Are Poised To Drive the Complicated Urinary Tract Infection Treatment Market at a CAGR Of 5.76%, As Per FMI
The global Complicated Urinary Tract Infections Treatment Market size is expected to surpass an impressive valuation of USD 9.2 billion in 2023 and is projected to reach USD 16.1 billion by 2033, trailing a CAGR of 5.76%. An advanced platform called biosensors are used for the diagnosis of complicated urinary tract infection which will drive …
Generalized Myasthenia Gravis (GMG) Managements Market to Reach a Valuation of US$ 2.96 Billion by 2033 Due to Growing Geriatric Population Globally
The global Generalized Myasthenia Gravis (GMG) Management Market is projected to poise a robust growth rate by exhibiting a compound annual growth rate (CAGR) of 7.6% from 2023 to 2033. The global market size is expected to surpass an impressive valuation of USD 1.32 Billion in 2023, the market is estimated to reach US$ 2.96 …
Increasing Demand for Frontotemporal Dementia Management to Propel the Growth at 6% CAGR through 2033: FMI Study
The global Frontotemporal Dementia Management Market is expected to garner a market value of US$ 10 Million in 2023 and is expected to accumulate a market value of US$ 17.91 Million by registering a CAGR of 6% in the forecast period 2023 to 2033. The market for Frontotemporal Dementia Management registered a CAGR of 4% …
Global Market for Tuberculous Meningitis Treatment to expand at a 7.2% CAGR from 2023 to 2033, reaching US$ 300 Billion: FMI Report
A recently published study by FMI expects the global tuberculous meningitis treatment market to augment at a 7.2% CAGR from 2023 to 2033. The global tuberculous meningitis treatment market garnered a market value of US$ 150 Billion in 2023, by the end of the said assessment period, a valuation of US$ 300 billion is expected for the market. Rapid advancements …
Idiopathic Pulmonary Fibrosis Management Market to Reach US$ 3649.90 Million by 2033: Focus on Developing New Drugs and Therapies | FMI
During the forecast period of 2023 to 2033, the global idiopathic pulmonary fibrosis management market is anticipated to grow at a CAGR of 1.5% from a market value of US$ 3145 million in 2023 to US$ 3649.90 million. The rising prevalence of the condition in men around the world is responsible for the expansion of …
Alpha-1 Antitrypsin Deficiency Market Booms to US$10 Billion by 2033, Propelled by a Noteworthy 12.8% CAGR | FMI Report
The global Alpha-1 Antitrypsin Deficiency market is poised to achieve a market value of US$3 billion in 2023, with projections indicating a remarkable growth to US$10 billion by 2033, driven by a substantial CAGR of 12.8% during the forecast period. The surge in respiratory illnesses plays a pivotal role in expanding the market. Furthermore, the …
FMI Reveals Remarkable Forecast for the Chronic Obstructive Pulmonary Disease (COPD): Expected to Reach US$33.19 Billion with a 4.4% CAGR by 2033
The worldwide market for Chronic Obstructive Pulmonary Disease (COPD) is anticipated to reach a substantial valuation of US$21.58 billion in the year 2023. As a consequence of the rising prevalence of alcohol consumption among individuals, the collective requirement for Chronic Obstructive Pulmonary Disease (COPD) is expected to experience a significant expansion, manifesting a commendable Compound …